Home Newsfeeds Barrington Research Downgrades CuriosityStream to Market Perform

Barrington Research Downgrades CuriosityStream to Market Perform

Barrington Research analyst James Goss downgrades CuriosityStream (NASDAQ:CURI) from Outperform to Market Perform.

byBenzinga Newsdesk

August 16, 2022

1 minute read

Barrington Research analyst James Goss downgrades CuriosityStream (NASDAQ:CURI) from Outperform to Market Perform.

Why Is Immuno-Oncology Focused Phio Pharmaceuticals Stock Trading Higher Today?

By Vandana Singh

October 11, 2:24 PM

Phio Pharmaceuticals Corp (NASDAQ: PHIO) shares are trading higher after the company announced the poster presentation of two preclinical studies of its INTASYL compound PH-894 at the AACR-NCI-EORTC International Conference on Molecular

PHIO

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

By Avi Kapoor

April 26, 1:56 PM

Shares of Aon plc (NYSE:AON) fell sharply during Friday’s session after the company reported worse-than-expected quarterly financial results.…

ACCD

Evercore ISI Group Maintains Outperform on Meta Platforms, Raises Price Target to $305

By Benzinga Newsdesk

March 14, 2:21 PM

Evercore ISI Group analyst Mark Mahaney maintains Meta Platforms (NASDAQ:META) with a Outperform and raises the price target from $275 to $305.

Sanofi Higher Dose Flu Vaccines Preferentially Recommended For Adults 65+ In CDC Morbidity And Mortality Weekly Report

By Benzinga Newsdesk

August 26, 8:04 AM

This recommendation may help reduce the risk of the flu and flu-related complications in this high-risk population Fluzone® High-Dose Quadrivalent (Influenza Vaccine) and

SNY

Barrington Research Downgrades CuriosityStream to Market Perform

Related Posts

Why Is Immuno-Oncology Focused Phio Pharmaceuticals Stock Trading Higher Today?

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday’s Mid-Day Session

Evercore ISI Group Maintains Outperform on Meta Platforms, Raises Price Target to $305

Sanofi Higher Dose Flu Vaccines Preferentially Recommended For Adults 65+ In CDC Morbidity And Mortality Weekly Report